Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2101]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test
ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower risk
ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower...
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
CRISPR-based mapping uncovers ‘switches’ for immune genes central to health
CRISPR-based mapping uncovers ‘switches’ for immune genes central to health
PKMYT1, a potential ‘Achilles heel’ of treatment resistant ER+ breast cancers with the poorest prognosis
PKMYT1, a potential ‘Achilles heel’ of treatment resistant ER+ breast cancers with the poorest prognosis
First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen
First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel...
The role of three-dimensional power doppler for detecting ovarian cancer in adnexal masses
The role of three-dimensional power doppler for detecting ovarian cancer in adnexal masses
Dogma-challenging telomere findings may offer new insights for cancer treatments
Dogma-challenging telomere findings may offer new insights for cancer treatments
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and, eventually, treatment
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and, eventually, treatment
Gene signatures from tissue-resident T cells as a predictive tool for melanoma patients
Gene signatures from tissue-resident T cells as a predictive tool for melanoma patients

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation